Nimodipine for vasospasm prophylaxis is typically administered orally at a dose of 60 mg every 4 hours, around the clock. This equates to a daily dose of 360 mg. Continuous administration is key for optimal prevention.
Monitoring and Adjustments
Regular blood pressure monitoring is crucial during nimodipine therapy due to its potential hypotensive effects. Dosage adjustments might be necessary based on individual patient responses and tolerance. Closely observe for signs of hypotension (low blood pressure) and bradycardia (slow heart rate). If these occur, reduce the dosage or consider alternative treatment strategies in consultation with a physician.
Special Considerations
Patients with hepatic impairment may require dosage reduction. Always consult the prescribing information for specific guidelines relating to patient-specific conditions. Always prioritize careful patient monitoring throughout the treatment duration.
Alternative Routes of Administration
While oral administration is standard, intravenous nimodipine exists; however, its use is typically reserved for specific clinical situations and requires careful monitoring under the guidance of a specialist.
